Page last updated: 2024-10-25

desipramine and Amyotrophic Lateral Sclerosis

desipramine has been researched along with Amyotrophic Lateral Sclerosis in 3 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Salado, IG1
Redondo, M1
Bello, ML1
Perez, C1
Liachko, NF1
Kraemer, BC1
Miguel, L1
Lecourtois, M1
Gil, C2
Martinez, A2
Perez, DI1
Nozal, V1
Martínez-González, L1
Gomez-Almeria, M1
Gonzalo-Consuegra, C1
Santana, P1
Chaikuad, A1
Pérez-Cuevas, E1
Knapp, S1
Lietha, D1
Ramírez, D1
Petralla, S1
Monti, B1
Martín-Requero, A1
Palomo, V1
de Lago, E1
Sawada, J1
Yamashita, T1
Aizawa, H1
Aburakawa, Y1
Hasebe, N1
Kwak, S1

Other Studies

3 other studies available for desipramine and Amyotrophic Lateral Sclerosis

ArticleYear
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.
    Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6

    Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Benzothiazoles; Blood-Brain B

2014
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; Case-Control Studies; DNA-Binding Proteins; Humans; I

2022
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Neuroscience research, 2009, Volume: 64, Issue:3

    Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine;

2009